General Asked Questions
For questions please send an email to EHENOFO@cdc.gov. A response to your question will be provided within 48 business hours.
General Asked Questions pdf icon[PDF – 402 KB]
General Information
Where can I find notice of funding opportunity (NOFO) PS20-2010: Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States?
To access the application package for PS20-2010: Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States
- Go to: www.grants.gov
- Select: “Applicants” from the top menu
- Select: “Apply for Grants”
- Select: “Download a Grant Application Package”
- In the “Funding Opportunity Number” box, type: CDC-RFA-PS20-2010
This website will be updated regularly with new information.
What are the key dates for this funding opportunity?
Publication: January 23, 2020
Applications Due: May 1, 2020
Award Date: August 1, 2020
Award Information
Approximate Period of Performance Length:
Component A: Ending the HIV Epidemic Initiative (Core Component) – 5 years
Component B: HIV Incidence Surveillance- 4 years (beginning in Year 2)
Component C: Scaling Up HIV Prevention Services in STD Clinics- 5 years
Approximate Number of Awards: 48
Component A: Ending the HIV Epidemic Initiative (Core Component) – 32
Component B: HIV Incidence Surveillance- 8 (beginning in Year 2)
Component C: Scaling Up HIV Prevention Services in STD Clinics- 5 – 8
Approximate Total Period of Performance Funding: $109,000,000
Average One Year Award Amount:
Component A: Funding will be determined by formulas reflecting a base funding amount, HIV disease prevalence, number of counties within the health department jurisdiction (if applicable), and program performance (in subsequent years).
Component B: $450,000 – $725,000
Component C: $400,000 – $800,000
What is the overall approach of this funding opportunity?
The overall approach is to implement the following components. Component A is the core component of this NOFO and therefore is required. Funding for Components B and C are optional and contingent upon submission of application for funding under Component A. Applicants should submit one application that is responsive to the requirements outlined under each of the components for which they intend to apply.
- Component A: Ending the HIV Epidemic Initiative (EHE) – Core component
- This component is intended to build on the on-going activities funded through PS18-1802: Integrated HIV Surveillance and Prevention Programs for Health Departments to strategically advance (i.e., initiate or expand) HIV prevention efforts. The included strategies and activities were strategically selected to maximize the ability of Phase 1 jurisdictions to achieve the EHE initiative goal of reducing all new infections by 75% in 5 years; focus efforts around the EHE four pillars; and facilitate transfer of knowledge and best practices from the Phase 1 jurisdictions to other jurisdictions so that the EHE goal of reducing all new infections by 90% can be achieved by 2030.
- Component B: HIV Incidence Surveillance
- This component will assess HIV incidence using a recent infection testing algorithm (RITA) and testing, clinical and other data collected by surveillance from persons newly diagnosed with HIV.
- Component C: Scaling up HIV prevention services in STD clinics
- The focus of this component is to: strengthen infrastructure and enhance and scale up quality HIV prevention services in STD specialty clinics; increase the number and percentage of STD clinic visits in which patients who are diagnosed with an acute STD and are not known to be HIV-infected are tested for HIV; increase uptake of PrEP/nPEP for those with acute STDs and are vulnerable for acquiring HIV infection; establish cost effective models for PrEP/nPEP services; and optimize linkage to, retention in, and re-engagement in HIV care and prevention services for patients who are HIV-positive and not in care or not virally suppressed.